RBC Capital analyst Natalia Webster raised the firm’s price target on Diaceutics (DIUXF) to 195 GBp from 165 GBp and keeps an Outperform rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DIUXF:
- Diaceutics Director Increases Stake Signaling Confidence in Company Growth
- Diaceutics Enhances Employee Incentive Program with Share Awards
- Diaceutics Reports Strong FY 2024 Growth and Positive Outlook
- Diaceutics Opens New US Headquarters to Boost Market Presence
- Diaceutics Unveils Pathology Engagement Service with $1.8m Contract
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue